Intuitive Surgical, Inc. (isrg)

Unlock full data in Terminal →

ISRG — Company Overview

Investors tracking ISRG follow a Medical Instruments & Supplies name listed on NMS within Healthcare.

Ticker	ISRG
Sector	Healthcare
Industry	Medical Instruments & Supplies
Exchange	NMS
Market cap	$133.89B
Last price	$373.71
Size category	Large Cap

ISRG — Business Description

The business profile of Intuitive Surgical, Inc. (ISRG) reflects its role in Medical Instruments & Supplies. Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of cus…

Official website: https://www.intuitive.com.

ISRG — Investment Thesis

Intuitive Surgical, Inc. (ISRG) attracts investors weighing Medical Instruments & Supplies fundamentals against current market pricing.

Revenue is expanding at roughly 18.5% year-over-year (public data).
Trailing P/E of 43.10× implies elevated growth expectations at the current price.
Forward P/E (30.96×) is below trailing P/E — earnings may be expected to improve.
Equity market capitalization is approximately $133.89B.

Analyst consensus, price targets & estimates is available in Vest Terminal for Professional and Enterprise subscribers.

ISRG — Financial Health

ISRG financial profile reflects operating efficiency and capital structure using available market fundamentals.

Profit margin of 28.4% indicates solid bottom-line conversion. Positive free cash flow of $2.62B supports balance-sheet flexibility.

Trailing P/E	43.10×
Forward P/E	30.96×
Price / Sales	12.13×
Price / Book	7.28×
Gross margin	66.7%
Operating margin	33.6%
Profit margin	28.4%
Return on equity	17.4%
Free cash flow	$2.62B

ISRG — Growth Outlook

Growth outlook for Intuitive Surgical, Inc. (ISRG) depends on demand trends in Medical Instruments & Supplies and the company's ability to convert revenue into sustainable earnings.

Revenue growth of 18.5% indicates strong top-line momentum.
Earnings growth of 26.5% year-over-year supports improving profitability.
Price is 38.1% below the 52-week high.
Shares trade 13.7% above the 52-week low — limited rebound so far.

ISRG — Competitive Position

Intuitive Surgical, Inc. (ISRG) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.

Competes within Healthcare, specifically in Medical Instruments & Supplies.
Market capitalization of $133.89B places ISRG among large-cap peers.
Gross margin near 66.7% may reflect pricing power or favorable mix.

ISRG — Strengths

Strengths for Intuitive Surgical, Inc. (ISRG) inferred from public financial metrics:

Revenue growth of 18.5% year-over-year.
Earnings growth of 26.5% year-over-year.
Return on equity near 17.4% — efficient use of shareholder capital.
Gross margin of 66.7% supports competitive unit economics.
Positive free cash flow ($2.62B).
Large Cap scale ($133.89B) may provide distribution and funding advantages.

ISRG — Weaknesses

Weaknesses and pressure points for Intuitive Surgical, Inc. (ISRG) based on available data:

Elevated trailing P/E (43.10×) limits valuation margin of safety.
High beta (1.46) amplifies market swings.
Price 38% below the 52-week high — sustained negative sentiment.

ISRG — Opportunities

Sustained revenue growth (18.5%) could support multiple expansion if margins hold.
Trading 13.7% above the 52-week low — potential recovery if fundamentals stabilize.
Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.
Forward earnings multiple below trailing P/E — potential earnings acceleration ahead.

ISRG — Risks

Beta of 1.46 implies above-market volatility.
Rich valuation (P/E 43.10×) increases downside if growth slows.

ISRG — Summary

Intuitive Surgical, Inc. (ISRG) is a large-cap Healthcare company focused on Medical Instruments & Supplies, listed on NMS. Last price $373.71 with market cap $133.89B. Trailing P/E 43.10×. Revenue grew 18.5% year-over-year per public data. Notable strengths include revenue growth of 18.5% year-over-year. Key watch items include elevated trailing p/e (43.10×) limits valuation margin of safety. For analyst estimates, ownership, and live news on ISRG, upgrade to Vest Terminal Professional.

Intuitive Surgical, Inc. FAQ

What does Intuitive Surgical, Inc. (ISRG) do?

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables sur…

What is ISRG's P/E ratio?

Intuitive Surgical, Inc. has a trailing P/E of 43.10× based on publicly available market data.

Does ISRG pay a dividend?

Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.

What sector is ISRG in?

Intuitive Surgical, Inc. is classified in Healthcare (Medical Instruments & Supplies) on NMS.

What is ISRG's market capitalization?

Approximate market cap: $133.89B.

What are the main risks for ISRG?

Key risks include above-average volatility (beta 1.46), elevated valuation, among factors on this page.

What are the strengths of ISRG?

Potential positives include revenue growth of 18.5% year-over-year, earnings growth of 26.5% year-over-year.

Where can I get analyst estimates for ISRG?

Consensus estimates, price targets, and detailed analyst data for Intuitive Surgical, Inc. are available to Professional subscribers in Vest Terminal — not on this public summary page.